Treatment outcomes of intravitreal ranibizumab for diabetic macular oedema in vitrectomised eyes
Vicky Hsin‐Ju Lu(Moorfields Eye Hospital), Ranjan Rajendram(University College London), Lyndon da Cruz(Moorfields Eye Hospital), Roger Wong(Frimley Park Hospital), Mark A. P. Fajgenbaum(St Thomas' Hospital), Sheelah Antao(Moorfields Eye Hospital), James Bainbridge(University College London), Robin Hamilton(Moorfields Eye Hospital NHS Foundation Trust)
UCL Discovery (University College London)
September 26, 2016
Cited by 0
Related Papers
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)
|Ophthalmology|2010|510
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration
|Ophthalmology|2016|183
Patterns of Peripheral Retinal and Central Macula Ischemia in Diabetic Retinopathy as Evaluated by Ultra-widefield Fluorescein Angiography
|American Journal of Ophthalmology|2014|142
Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting
|American Journal of Ophthalmology|2016|86
Widefield optical coherence tomography angiography for early detection and objective evaluation of proliferative diabetic retinopathy
|British Journal of Ophthalmology|2020|68